Hudson Executive Capital is a fund manager in New York with $1.45 bn assets under management.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
Corporate docs
IRS number
472878186
SEC advisor number
801-96334
FINRA CRD number
175032
AUM ?
$1.15 bn
(as of 29 Mar 24)
Accounts
9
(as of 29 Mar 24)
Employees
3
(2 investment advisory or research)
Address
Hudson Executive Capital
570 LEXINGTON AVENUE, 35TH FLOOR
NEW YORK
NY 10022
570 LEXINGTON AVENUE, 35TH FLOOR
NEW YORK
NY 10022
Phone
(212) 521-8495
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Hudson Executive Capital LP | $1.45 bn | |
Hec Investment Fund Cayman Master LTD | $797.36 mm | Hedge Fund |
Hec SPV II Cayman LP | ||
Hec SPV II Master Fund LP | ||
Hec SPV II USA LP | ||
Hec Master Fund LP | $622.33 mm | Hedge Fund |
Hec Intermediate Fund LP | ||
Hec Offshore Fund LTD | ||
Hec Onshore Fund LP | ||
Hec SPV IV LP | $26.51 mm | Hedge Fund |
Hec SPV V LP | Hedge Fund |
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
20 Apr 20
DFAN14A
Additional proxy materials by non-management
9 Apr 20
DFAN14A
Additional proxy materials by non-management
9 Apr 20
DFRN14A
Revised proxy by non-management
9 Apr 20
DFAN14A
Additional proxy materials by non-management
6 Apr 20
DFAN14A
Additional proxy materials by non-management
6 Apr 20
DFAN14A
Additional proxy materials by non-management
6 Apr 20
DFRN14A
Revised proxy by non-management
31 Mar 20
DFAN14A
Additional proxy materials by non-management
30 Mar 20
DFAN14A
Additional proxy materials by non-management
24 Mar 20
Latest ownership filings
4
Douglas L Braunstein
21 Feb 24
SC 13D/A
CANTALOUPE, INC.
21 Feb 24
144
CANTALOUPE, INC.
21 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
SC 13D/A
ViewRay, Inc.
21 Jul 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
SC 13D/A
Akoya Biosciences, Inc.
7 Feb 23